The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery

Detalhes bibliográficos
Autor(a) principal: Neves, Bruno Junior
Data de Publicação: 2016
Outros Autores: Dantas, Rafael Ferreira, Senger, Mario Roberto, Valente, Walter César Góes, Rezende Neto, João de Mello, Chaves, William Távora, Kamentsky, Lee, Carpenter, Anne, Silva Junior, Floriano Paes, Andrade, Carolina Horta
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/14784
Resumo: Universidade Federal de Goiás. Faculdade de Farmácia. Laboratório de Modelagem Molecular e Design. Goiânia, GO, Brasil.
id CRUZ_f54791bd05ee417500e9725de4eecf2d
oai_identifier_str oai:www.arca.fiocruz.br:icict/14784
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Neves, Bruno JuniorDantas, Rafael FerreiraSenger, Mario RobertoValente, Walter César GóesRezende Neto, João de MelloChaves, William TávoraKamentsky, LeeCarpenter, AnneSilva Junior, Floriano PaesAndrade, Carolina Horta2016-07-05T17:13:15Z2016-07-08T12:22:02Z2016-07-05T17:13:15Z2016-07-08T12:22:02Z2016NEVES, Bruno Junior; etal. The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery. MedChemComm, v.7, p.1176-1182, Apr. 2016.2040-2503https://www.arca.fiocruz.br/handle/icict/1478410.1039/c5md00596e2040-2511engRoyal Society of ChemistryEsquistossomoseMedicamento antidepressivoParoxetinaschistosomeAntidepressant drugParoxetine (PAR)The antidepressant drug paroxetine as a new lead candidate in schistosome drug discoveryinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Goiás. Faculdade de Farmácia. Laboratório de Modelagem Molecular e Design. Goiânia, GO, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Broad Institute of Massachusetts Institute of Technology and Harvard. Imaging Platform. Cambridge, Massachussetts, USA.Broad Institute of Massachusetts Institute of Technology and Harvard. Imaging Platform. Cambridge, Massachussetts, USAFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.Universidade Federal de Goiás. Faculdade de Farmácia. Laboratório de Modelagem Molecular e Design. Goiânia, GO, Brasil.Recently, our in silico repositioning-chemogenomics approach predicted paroxetine (PAR), an antidepressant drug, as a inhibitor of Schistosoma mansoni serotonin transporters (SmSERTs), and consequently, a new anti-schistosomal candidate. With the aim of determining the anti-schistosomal activity of this drug, we initially used a spectrophotometric assay to determine activity against schistosomula worms. During this investigation, we verified that PAR showed a pronounced effect on schistosomula viability (IC50 = 2.5 μM) after 72 h of incubation. Then, we performed ex vivo studies with adult S. mansoni worms using a new automated image-based assay to accurately measure worm motility. As expected from the PAR's predicted mechanism of action, both male and female worms treated with low concentrations of PAR exhibited enhanced motility followed by reduction in motility as incubation time increased. PAR EC50 values for motility reduction in male and female worms were 5.1 μM and 9.9 μM after 24 h of exposure, respectively, and this effect was maintained until the end of the experiment (72 h). Lastly, homology modeling and docking studies with SmSERT-A and human SERT (hSERT) revealed insights into the chemical basis of PAR antischistosomal activity. These results provide crucial guidance for further studies to optimize PAR in terms of potency and selectivity.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZTEXTwalter_valente_etal_IOC_2016.pdf.txtwalter_valente_etal_IOC_2016.pdf.txtExtracted texttext/plain33924https://www.arca.fiocruz.br/bitstream/icict/14784/4/walter_valente_etal_IOC_2016.pdf.txtd0068750e5630bac6431fece654196daMD54ORIGINALwalter_valente_etal_IOC_2016.pdfapplication/pdf3152264https://www.arca.fiocruz.br/bitstream/icict/14784/2/walter_valente_etal_IOC_2016.pdf5f57b17c051e5ab5c408b304050e98d6MD52LICENSElicense.txttext/plain2991https://www.arca.fiocruz.br/bitstream/icict/14784/3/license.txt5a560609d32a3863062d77ff32785d58MD53icict/147842022-06-24 13:08:51.3oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-06-24T16:08:51Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
title The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
spellingShingle The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
Neves, Bruno Junior
Esquistossomose
Medicamento antidepressivo
Paroxetina
schistosome
Antidepressant drug
Paroxetine (PAR)
title_short The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
title_full The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
title_fullStr The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
title_full_unstemmed The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
title_sort The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
author Neves, Bruno Junior
author_facet Neves, Bruno Junior
Dantas, Rafael Ferreira
Senger, Mario Roberto
Valente, Walter César Góes
Rezende Neto, João de Mello
Chaves, William Távora
Kamentsky, Lee
Carpenter, Anne
Silva Junior, Floriano Paes
Andrade, Carolina Horta
author_role author
author2 Dantas, Rafael Ferreira
Senger, Mario Roberto
Valente, Walter César Góes
Rezende Neto, João de Mello
Chaves, William Távora
Kamentsky, Lee
Carpenter, Anne
Silva Junior, Floriano Paes
Andrade, Carolina Horta
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Neves, Bruno Junior
Dantas, Rafael Ferreira
Senger, Mario Roberto
Valente, Walter César Góes
Rezende Neto, João de Mello
Chaves, William Távora
Kamentsky, Lee
Carpenter, Anne
Silva Junior, Floriano Paes
Andrade, Carolina Horta
dc.subject.other.pt_BR.fl_str_mv Esquistossomose
Medicamento antidepressivo
Paroxetina
topic Esquistossomose
Medicamento antidepressivo
Paroxetina
schistosome
Antidepressant drug
Paroxetine (PAR)
dc.subject.en.pt_BR.fl_str_mv schistosome
Antidepressant drug
Paroxetine (PAR)
description Universidade Federal de Goiás. Faculdade de Farmácia. Laboratório de Modelagem Molecular e Design. Goiânia, GO, Brasil.
publishDate 2016
dc.date.accessioned.fl_str_mv 2016-07-05T17:13:15Z
2016-07-08T12:22:02Z
dc.date.available.fl_str_mv 2016-07-05T17:13:15Z
2016-07-08T12:22:02Z
dc.date.issued.fl_str_mv 2016
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv NEVES, Bruno Junior; etal. The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery. MedChemComm, v.7, p.1176-1182, Apr. 2016.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/14784
dc.identifier.issn.pt_BR.fl_str_mv 2040-2503
dc.identifier.doi.pt_BR.fl_str_mv 10.1039/c5md00596e
dc.identifier.eissn.pt_BR.fl_str_mv 2040-2511
identifier_str_mv NEVES, Bruno Junior; etal. The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery. MedChemComm, v.7, p.1176-1182, Apr. 2016.
2040-2503
10.1039/c5md00596e
2040-2511
url https://www.arca.fiocruz.br/handle/icict/14784
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Royal Society of Chemistry
publisher.none.fl_str_mv Royal Society of Chemistry
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/14784/4/walter_valente_etal_IOC_2016.pdf.txt
https://www.arca.fiocruz.br/bitstream/icict/14784/2/walter_valente_etal_IOC_2016.pdf
https://www.arca.fiocruz.br/bitstream/icict/14784/3/license.txt
bitstream.checksum.fl_str_mv d0068750e5630bac6431fece654196da
5f57b17c051e5ab5c408b304050e98d6
5a560609d32a3863062d77ff32785d58
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798325043904643072